Triethylamine → (R)-Quinuclidin-3-yl ((S)-(3-((3-((4,4-diethoxybutyl)carbamoyl)-1-methyl-1H-pyrazol-5-yl)methoxy)phenyl)(phenyl)methyl)carbamate
反応式
[CH3:1][N:2]1[C:6]([CH2:7][O:8][C:9]2[CH:14]=[CH:13][CH:12]=[C:11]([C@H:15]([C:28]3[CH:33]=[CH:32][CH:31]=[CH:30][CH:29]=3)[NH:16][C:17]([O:19][C@@H:20]3[CH:25]4[CH2:26][CH2:27][N:22]([CH2:23][CH2:24]4)[CH2:21]3)=[O:18])[CH:10]=2)=[CH:5][C:4]([C:34](O)=[O:35])=[N:3]1.C(N(CC)CC)C.[CH2:44]([O:46][CH:47]([O:52][CH2:53][CH3:54])[CH2:48][CH2:49][CH2:50][NH2:51])[CH3:45].CCN=C=NCCCN(C)C.OC1C=CC=C[N+]=1[O-]>CN(C=O)C.C(OCC)(=O)C>[N:22]12[CH2:27][CH2:26][CH:25]([CH2:24][CH2:23]1)[C@@H:20]([O:19][C:17](=[O:18])[NH:16][C@H:15]([C:11]1[CH:12]=[CH:13][CH:14]=[C:9]([O:8][CH2:7][C:6]3[N:2]([CH3:1])[N:3]=[C:4]([C:34](=[O:35])[NH:51][CH2:50][CH2:49][CH2:48][CH:47]([O:46][CH2:44][CH3:45])[O:52][CH2:53][CH3:54])[CH:5]=3)[CH:10]=1)[C:28]1[CH:29]=[CH:30][CH:31]=[CH:32][CH:33]=1)[CH2:21]2参加物
8
反応物 5
生成物 1
試薬・触媒・溶媒 2
実験手順
To a stirred solution of 1-methyl-5-((3-((S)-phenyl((((R)-quinuclidin-3-yloxy)carbonyl)amino)methyl)phenoxy)methyl)-1H-pyrazole-3-carboxylic acid (0.30 g, 0.61 mmol) in DMF (6 mL) was added triethylamine (0.2 mL, 1.53 mmol), 4-aminobutyraldehyde diethyl acetal (0.20 mL, 1.22 mmol), EDCI (0.18 g, 0.91 mmol) and 2-hydroxypyridine-N-oxide (0.09 g, 0.91 mmol). The reaction mixture stirred at RT for 90 h. The reaction mixture was diluted with ethyl acetate and washed with saturated sodium hydrogen carbonate, brine, dried (magnesium sulfate), filtered and the solvent evaporated at reduced pressure to afford the crude target material (0.22 g, 57%) which was used directly without further purification.
後処理
- washwashed with saturated sodium hydrogen carbonate, brine
- dry with materialdried (magnesium sulfate)
- filtrationfiltered
- customthe solvent evaporated at reduced pressure
出典と根拠
- ORDレコード
- ord-f9f2c2bc164e4d6bbfb164213a227c6c
- 出典データセット
- uspto-grants-2015_03
- 特許番号
- US08987299B2
反応ノート
読み込み中…